A disruptive technology to tackle brain cancer and glioblastoma
News
Hemerion trains first US neurosurgery team on its glioblastoma treatment solution
Hemerion recently completed the final preparations for the start of its next clinical trial in the US. Set-up, verification of equipment and procedures, training of a first neurosurgery team: Hemerion… ...
Hemerion named one of Challenges magazine’s “100 startups worth investing in”.
Every year since 2014, the business magazine Challenges has singled out the "100 startups to invest in". A true benchmark for investors, this ranking welcomes Hemerion for the first time… ...
Prof. Hadjipanayis, member of Hemerion’s Scientific Advisory Board, named “Top Doctor” in Neurosurgery by Castle Connolly in the USA
Prof. Hadjipanayis has been named "Top Doctor" in the Neurosurgery category by the independent organization Castle Connolly. This ranking is established each year and recognizes 7% of the best American… ...
Stay tuned to our clinical advances
They talk about us
